Interstitial Lung Fibrosis Drugs In Development
May 4, 2023 ⚊ 1 Min read ⚊ Views 61 ⚊ TECHNOLOGYInterstitial lung fibrosis (ILF) is a chronic lung disease that affects the lung’s interstitium, the thin layer of tissue that surrounds the air sacs in the lungs. The disease causes the interstitium to become thickened and scarred, making it difficult for oxygen to pass from the lungs into the bloodstream. ILF can have a significant impact on a patient’s quality of life and can ultimately lead to respiratory failure and death. Currently, there is no cure for ILF, and treatment options are limited. However, there are several drugs in development that show promise in treating this devastating disease.
Tags: Interstitial Lung Fibrosis Drugs